No active 13F manager changed its position in RADX last quarter. No recent Form 4 insider filings for RADX.
No leg leans either way.
6 tracked 13F filers disclose a position in RADX as of the latest SEC 13F filings, a combined $1.2M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Stonepine Capital Management, LLC | 51.0M | $671K | —Held | Q2 2026 | |
| 2 | HSBC Holdings PLC | 61K | $265K | ▼−68% Reduced · −130K sh | Q1 2026 | |
| 3 | Regal Partners Ltd | 40K | $168K | —Held | Q2 2026 | |
| 4 | PNC Financial Services Group, Inc. | 16K | $69K | —Held | Q1 2026 | |
| 5 | UBS Group AG | 3K | $13K | ▼−79% Reduced · −11K sh | Q1 2026 | |
| 6 | Rhumbline Advisers | 121 | $519 | ▲20× Added · +115 sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Their position there |
|---|---|---|
| Newmont CorpNEM | 1 funds | $180.7M |
| Apollo Global Management IncAPO | 1 funds | $166.0M |
| Bank Of America CorpBAC | 1 funds | $149.9M |
| Royalty Pharma PLC- CL ARPRX | 1 funds | $137.3M |
| Schwab (Charles) CorpSCHW | 1 funds | $122.1M |
| Sanofi-ADRSNY | 1 funds | $113.2M |
| Freeport-McMoran IncFCX | 1 funds | $109.0M |
| Teck Resources Ltd-CLS BTECK | 1 funds | $101.1M |
| Wynn Resorts LtdWYNN | 1 funds | $87.2M |
| Walt Disney CoDIS | 1 funds | $76.0M |
| Union Pacific CorpUNP | 1 funds | $74.4M |
| Wells Fargo & CoWFC | 1 funds | $68.7M |
Ranked by how many of RADX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in RADX.
No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 1 | 2 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
No filings captured for this ticker in the live stream yet.
Connected entities for RADX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/RADX/capital-change-brief"
Use Arkolith's capital_change_brief for RADX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for RADX. Filings are public domain, sourced to SEC EDGAR.